Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 Gennaio 2022 News Veterinary Maximum residue limit Medicines International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 Gennaio 2022 News Human COVID-19 COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 Gennaio 2022 News Human COVID-19 Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 Gennaio 2022 News Human COVID-19 Pharmacovigilance Referrals Vaccines EMA welcomes EU Commissioner for Health and Food Safety 13 Gennaio 2022 News Corporate COVID-19 Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 Gennaio 2022 News Human Clinical trials Global regulators discuss path towards regulatory alignment on response to Omicron variant 13 Gennaio 2022 News Human COVID-19 Vaccines Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant 11 Gennaio 2022 News Human COVID-19 Vaccines EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19 10 Gennaio 2022 News Human COVID-19 Medicines Emer Cooke’s end-of-year message 22 Dicembre 2021 News Corporate COVID-19 1 … 46 47 48 49 50 Page 50 of 379 51 52 53 54 … 379
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 Gennaio 2022 News Veterinary Maximum residue limit Medicines
International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 Gennaio 2022 News Human COVID-19
COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 Gennaio 2022 News Human COVID-19 Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 Gennaio 2022 News Human COVID-19 Pharmacovigilance Referrals Vaccines
Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 Gennaio 2022 News Human Clinical trials
Global regulators discuss path towards regulatory alignment on response to Omicron variant 13 Gennaio 2022 News Human COVID-19 Vaccines
Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant 11 Gennaio 2022 News Human COVID-19 Vaccines
EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19 10 Gennaio 2022 News Human COVID-19 Medicines